Insider filing · CMPX

Carl L Gordon sold $5.7M of Compass Therapeutics (CMPX)

Executed Apr 9 2025, disclosed Apr 11 2025, 2 days later.

Returns are measured on stock purchases only.

CG Carl L Gordon Director profile →

Carl L Gordon (Director) filed 5 Form 4 reports in the trailing twelve months (5 purchases, 0 sales), most often in Electra Therapeutics, Inc. (ETRA). Across 4 priced purchase filings, the average 21-session return was +17.0% from execution and +14.9% from disclosure (delay-adjusted; derived). The largest single filing was $20.0M of ETRA (1,333,333 sh across 2 lots, as filed), executed Sep 21.

CMPX CMPX CMPX · 2 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→